Altria Group, Inc.
MONYSECigarettesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/304% above fair value
$77.17−0.86 (-1.10%)
Close on Nov 2, 2026Market cap $128.85BP/E 15.9Yield 5.39%
Altria DB Segment Operating Companies Income: Oral Tobacco by Quarter
DB Segment Operating Companies Income: Oral Tobacco Products ($M) ($M)
Altria DB Segment Operating Companies Income: Oral Tobacco: $434M in Q3 2026, down 5.4% from a year earlier.
Latest, Q3 2026
434
Period ended Sep 30, 2026
Change on a year earlier
-5.4%
459 in Q3 2025
History
47 quarters
Since Q3 2014
Sources
31
Documents cited below
Where the Q3 2026 figure comes from
“|| Reported OCI | $ | 434 | $ | 459 | (5.4) | % | $ | 1,250 | $ | 1,390 | (10.1) | %”
Source: Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-26-000112), filed 2026-10-29 ↗
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Altria DB Segment Operating Companies Income: Oral Tobacco ($M), quarterly Q3 2014–Q3 2026 [Data set]. Compiled from Altria SEC filings and investor materials. https://stockdatahq.com/stocks/mo/kpis/ctx-seg-oral-oi
See every metric in the Altria KPI table. Data updated Nov 2, 2026.